The TRN surrounds the entire anteroposterior extent of the dorsal thalamus, meaning all thalamo-9 cortical and cortico-thalamic projections must pass through and make connections with its mesh of 10 inhibitory interneurons (Houser et al., 1980; Jones, 1985) (FIG. 1) . This strategic localisation between 11 thalamus and cortex enables the TRN to mediate coherent activity patterns within the thalamo-12 cortico-thalamic excitatory loop by providing both feedback and feedforward inhibition to thalamic 13 nuclei upon thalamo-cortical and cortico-thalamic input, respectively (Shosaku et al., 1989) (FIG. 1) . 14 The Group II metabotropic glutamate (mGlu) receptors (mGlu2/3) modulate physiologically-evoked 15 responses in the somatosensory ventrobasal thalamic nucleus (VB) by reducing inhibition from the 16 TRN (Salt & Turner, 1998; Copeland et al., 2012) , with the mGlu2 component to this Group II effect 17 likely activated by glutamate spillover upon physiological sensory stimulation (Copeland et al., 2012) . 
29
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2 VB astrocytes in vitro can respond to sensory afferent stimulation with an elevation in intracellular 30 calcium (Parri et al., 2010) , in accordance with astrocytic activation in other brain regions (Porter & 31 McCarthy, 1996; Grosche et al., 1999; D'Ascenzo et al., 2007) . These elevations can initiate release of 32 gliotransmitters including glutamate (Fellin et al., 2004) , D-serine (Panatier et al., 2006) , adenosine 33 triphosphate (Guthrie et al., 1999) and adenosine (Winder et al., 1996) , with subsequent modulation 34 of neuronal excitability and synaptic transmission (Fellin et al., 2004; Serrano et al., 2006) . Astrocytic 35 processes co-localise with sensory and TRN afferent terminals around the soma and proximal 36 dendrites of VB neurons (Ralston, 1983; Ohara & Lieberman, 1993) ; thus, it is important to 37 understand how astrocytes are activated as concomitant gliotransmission may represent a 38 significant mechanism in the regulation of thalamo-cortical network function via modulation of the 39 TRN-VB synapse. 40
41
Here, by firstly using in vitro electrophysiology we confirmed the presence of an mGlu2 component 42 to the overall Group II mGlu receptor effect on inhibitory synaptic transmission from the TRN to the 43 VB, as previously indicated in vivo (Copeland et al, 2012) . By then using in vitro calcium imaging, 44 which enabled the identification of the cellular foundation supporting this mechanism, the mGlu2 45 component was identified as astrocyte-dependent: mGlu2 receptor activation elicited elevations in 46 astrocytic (but not neuronal) intracellular calcium -a novel mechanism of astrocyte activation. 47 M A N U S C R I P T
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The recording chamber and manipulators were mounted on a motorized moveable bridge (Luigs and  153 Neumann) and fluorescence dyes were excited using an Optoscan monochromator system, fitted to 154 a Nikon FN1 upright microscope; filter cubes for selective Fura-2, Fluo4 and SR101 imaging were 155 obtained from Chroma. Images of slice areas of 444µm x 341µm were routinely acquired every 5s 156 with a x20 objective lens (NA=0.8) using an ORCA ER CCD camera (Hamamatsu) and analysed using 157
Simple PCI software (Hamamatsu). Fluorescence values over time for specific regions of interest 158 (ROIs) were exported and analysed using Sigmaplot (Systat). All experiments were conducted using adult male Wistar rats (340-540g, n=18). Animals (Harlan, UK) 171 were housed on a 12h light/dark cycle with food and water ad libitum. prepared for recording as previously described (Salt, 1987 (Salt, , 1989 performed using the outer barrels (Salt, 1987 (Salt, , 1989 ). On each occasion, one of the outer barrels was 185 filled with 1M NaCl for current balancing. The remaining outer barrels each contained one of the 186 solenoid valves that produced a rising air pulse at the vibrissa 8ms after switching. Response 209 latencies were calculated from the start of the gating pulse. Using such an approach it is possible to 210 use air-jets to evoke an excitatory response from stimulation of a single vibrissa, as described 211 previously (Salt, 1989) . Prior to the beginning of each of the experimental protocols described 212 below, the 'principal' vibrissa (i.e. the vibrissa at the centre of the receptive field) for each neuron 213 was identified. All neurons recorded from were quiescent. 214
PROTOCOL 1 215
The effects of the selective glial inhibitor fluorocitrate on VB neuronal responses to train 216 stimulation of vibrissae and iontophoretic NMDA application 217
Cycles of sensory and NMDA stimulation were established and repeated continuously whilst 218 recording from neurons. Cycles (60s long) contained two types of stimuli consisting of 500-219 1000ms duration trains (5-10Hz) of air-jets directed at the principal vibrissa, repeated 4 220 times with a 4s interstimulus interval, followed by a single iontophoretic NMDA application 221 (10s), which was timed to provide a 15s interval either side of the sensory stimulations. and an mGlu2 component to this Group II effect was recently described in an in vivo study (Copeland 269 et al., 2012) . Therefore, we first determined whether mGlu2 receptor activation is able to modulate 270 inhibitory synaptic transmission at the TRN-VB synapse. One component that would contribute to 271 IPSP depression is direct inhibition of GABAergic vesicle fusion with the presynaptic TRN membrane. 272
By recording miniature inhibitory postsynaptic currents (mIPSCs) it is possible to examine the 273 frequency of spontaneous presynaptic quantal release events and so detect changes in transmitter 274 M A N U S C R I P T
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12 release in the absence of evoked synaptic activity. In the absence of endogenous mGlu2 receptor 275 activation, a sub-maximal concentration (30nM) of the Group II agonist LY354740 was able to reduce 276 mIPSC frequency compared to baseline when applied alone (10.0±1.6% reduction compared to 277 control, n=6 from 6 slices , FIG. 2) . Application of the mGlu2 PAM LY487379 alone had no effect on 278 mIPSC frequency (data not shown). By nature of design, PAMs potentiate the action of orthosteric 279 agonists, without themselves possessing any intrinsic agonist activity (Johnson et al., 2003) . This lack 280 of effect of the PAM in this preparation is therefore unsurprising as there is likely no baseline 281 activation of mGlu2 receptors under these conditions. However, when the mGlu2 PAM was co-282 applied with the sub-maximal concentration of Group II agonist, a significant additional reduction in 283 
MGLU2 RECEPTORS ACTIVATE ASTROCYTES IN THE VB
297
Are mGlu2 receptors themselves able to directly activate astrocytes? To address this question, we 298 monitored intracellular calcium levels in both VB neurons and astrocytes in an acute in vitro thalamic 299 slice preparation. In the presence of TTX to block neuronal activity, a sub-maximal concentration of 300 the Group II orthosteric agonist induced increases in intracellular calcium levels compared toM A N U S C R I P T 302   FIG. 3a-c) . Application of the mGlu2 PAM alone had no effect on intracellular calcium levels (data not 303 shown). Upon co-application of the mGlu2 PAM with the agonist there was a significant potentiation 304 in astrocytic intracellular calcium levels in the same astrocytes (300nM LY354740 plus 30μM 305 LY487379, ratio amplitude 0.035±0.003, n=56 astrocytes from 5 slices, p<0.001; FIG. 3a-c) . This 306
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Group II mGlu receptor effect could be reversed upon co-application of 1µM of the Group II 307 antagonist LY341495 (1µM LY354740, 2.11±0.45 ΔF% change; 1µM LY354740 plus 1µM LY341495, 308 0.28±0.17ΔF% change, n=10 astrocytes from 5 slices, p<0.01; FIG. 3d) . Co-application of the Group II 309 agonist with 5μM 2-Methyl-6-(phenylethynyl)pyridine (MPEP) and 100μM suramin had no effect 310 
ASTROCYTES GATE NEURONAL RESPONSES TO SOMATOSENSORY STIMULATION
347
Does this mechanism modulate thalamocortical responses to sensory stimulation in an in vivo 348 system (FIG. 4A) ? To test this question, we first assessed whether astrocytes contribute to the 349 generation of VB neuron responses to physiological somatosensory stimulation. A recording 350 electrode with iontophoretic capabilities was advanced into the VB of rats, and vibrissae were 351 deflected as required to generate physiologically relevant activity. Observed waveforms were similar 352 to those previously published (Salt, 1989) , and were not perturbed under experimental conditions. 353
Fluorocitrate selectively inhibits glia by interfering with the astrocytic tricarboxylic acid cycle 354 (Fonnum et al., 1997) , which is used to generate energy in the form of guanosine triphosphate 355 (GTP). Upon local application of fluorocitrate, a reduction in neuronal responses to repetitive 10HzM A N U S C R I P T
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15 stimulation (1s duration) of the principal vibrissae was observed. Specifically, the maintained 357 component of the neuronal response profile was significantly reduced (68±4% of control, n=16 from 358 9 rats, p<0.001), whereas the initial component remained unaffected (101±3% of control, n=16 from 359 9 rats, p>0.05) (FIG. 4B,C) . The maintained component of neuronal responses to vibrissa stimulation 360 comprises an NMDA-mediated contribution under normal physiological conditions (Salt, 1986) . 361
However, neuronal responses to exogenous NMDA application were unaffected in the presence of 362 fluorocitrate (102±4% of control, n=11 from 5 rats, p>0.05) (FIG. 4B RIGHT PANELS; FIG. 4C been able to identify a novel mechanism of mGlu2 receptor-mediated astrocytic activation. In 392 summary, our in vitro experiments showed that selective potentiation of mGlu2 receptor activity 393 contributes to reducing inhibitory transmission at the TRN-VB synapse, and delineate the anatomical 394 localisation of these mGlu2 receptors to astrocytes, whose processes are known to co-localise with 395 TRN terminals on the soma and/or proximal dendrites of VB neurons (Ralston, 1983; Ohara & 396 Lieberman, 1993) (FIG. 6) . Our in vivo experiments extend our in vitro findings, showing that selective 397 potentiation of mGlu2 receptor activity leads to an astrocyte-dependent increase in VB neuron 398 responsiveness to somatosensory stimulation in a physiological context. This mechanism likely 399 occurs upon physiological sensory stimulation as previously described, with the source of 400 endogenous glutamate being glutamate spillover from the sensory afferent terminals activating 401 mGlu2 receptors localised on the glial processes (Copeland et al., 2012) . Therefore, we provide the 402 first evidence that physiological activation of astrocytic mGlu2 receptors leads to concomitant 403 modulation of thalamic processing of sensory inputs. Furthermore, previously the mGlu3 and mGlu5 404 receptor subtypes have been shown to be expressed in astrocytes (Niswender & Conn, 2010) , with 405 the mGlu5 subtype shown to mediate sensory driven activation of thalamic astrocytes (Parri et al., 406 2010) . We have now shown functional astrocytic mGlu2 receptors are also able to elicit an increase 407 in astrocytic intracellular calcium levels. 
HIGHLIGHTS
• Thalamic inhibition is mediated by both neuronal and astrocytic mechanisms.
• Group II mGlu receptor (mGlu2/3) activation can modulate this thalamic inhibition.
• Thalamic astrocytes can be activated upon mGlu2 receptor stimulation.
• This process may enable relevant activity to be discerned from background noise.
• Targeting astrocytic mGlu2 receptors may therefore affect attention and cognition.
